Fighting pharmaceutical companies for willful wrongdoing.
Unreasonably dangerous prescription drugs and defective medical devices harm or kill thousands of Americans every year. Our firm is involved with and has successfully resolved numerous cases involving dangerous drugs and devices, many with names you may have heard of before: Fen-Phen, Denture Adhesives, Baycol, Zyprexa, and defective hip implants. Among our current cases:
IVC Filters. During the last few years, the introduction of a temporary and retrievable IVC filter has created problems whereby body tissue grows around the device, causing the device to break, migrate, and lead to organ damage, injuries, and even deaths. Learn more.
Xarelto. Xarelto is a new generation blood thinner (anticoagulant). It can lead to uncontrollable bleeding, causing severe injuries and death. Learn more.
Actos. Diabetics taking Actos (pioglitazone) for more than one year may have a significantly increased risk of bladder cancer according to an FDA interim review of an ongoing epidemiological study. Data from an ongoing study of more than 193,000 patients with diabetes shows that those who used Actos for over one year or who used the highest cumulative dose of Actos were at a greater risk of bladder cancer. If you take Actos and have blood or red color in your urine, an urgent need to urinate, pain while urinating, or pain in the back or lower abdomen, as these may be symptoms of bladder cancer. Call your doctor immediately. And if you have bladder cancer and have taken Actos and wish to discuss your legal rights, contact us.
Transvaginal Pelvic Mesh. Women who have had a vaginal mesh patch implanted, typically to treat Pelvic Organ Prolapse (POP) or Stress Urinary Incontinence (SUI), may be at risk for a number of internal injuries. Transvaginal mesh implants can cause extrusion of the mesh through the vaginal wall or nearby organs, chronic pain, pain during intercourse, infections, perforations of the bowel, bladder, and blood vessels, vaginal scarring, and recurrence of the conditions for which the mesh was implanted in the first place. Learn more.
Low-Testosterone drugs. Low-T drugs that are constantly advertised may double the risks of heart attack in men over age 65 and triple the risk of heart attack in men under 65 who had other cardiovascular risk factors. Learn more.
Risperdal. This is an atypical anti-psychotic drug for the treatment of symptoms of schizophrenia, bipolar disorder, and autism. It has been linked to a condition in boys called “gynecomastia,” or male breasts, which is obviously a humiliating condition for any boy. Surgery may be required to correct the condition. The drug, which has been prescribed or uses not authorized by the FDA, is manufactured by Ortho-McNeil Janssen Pharmaceuticals, Inc., a Johnson & Johnson subsidiary. Johnson & Johnson settled the first Risperdal male breast case in 2012.
Stryker Rejuvenate and ABG II Modular Hip systems. These modular hip systems were recalled in June 2012 due to corrosion. The authors of a medical journal article estimate that a “strikingly” high percentage of hip implants will fail because of corrosion and need to be surgically removed and replaced within two to four years of implantation. If you have been implanted with a Stryker Rejuvenate or ABG II hip system, the terms of the recall state that you should return to your surgeon. Please contact us to discuss your legal rights or for information about the Stryker hip recall.
DePuy Orthopaedics metal-on-metal hip implant. Involves both the ASR and Pinnacle models. We represent dozens of clients involved in these metal-on-metal hip implant litigations.
If you would like to discuss your legal rights and remedies, please contact the experienced dangerous drug and defective medical device products liability attorneys at Phelan | Petty, PLC.